Immuno Oncology Assays Market: By Product Type By Technology, Next-generation sequencing, Flow Cytometry Others) By Indication By Application and Region Forecast 2019 - 2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Immuno Oncology Assays Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Instruments, Reagents and Kits, Software and Services) By Technology (Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others) By Indication (Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma Cancer, Bladder Cancer Others) By Application (Clinical Diagnostics, Research Application) and Region Forecast 2019 - 2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Immuno oncology assays market size was valued at US$ 2,798.6 million in 2023 growing at a significant CAGR of 12.5% from 2024 to 2030. The global market provides a detailed overview of the market, and that can be segmented by Product Type, by Technology, by Indication, and by Application. By product type, the global market has been segmented into Instruments, Reagents and Kits, Software and Services. The software & services segment is likely to be the largest and fastest-growing Segment in terms of type. Based on technology, the global market is segmented into Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others. Among these, the Polymerase chain reaction (PCR) segment is expected to have the fastest-growing market during the forecast period 2024-2030.

Based on indication, the global Immuno market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer Treatment, Melanoma Cancer, Bladder Cancer, Others. The lung cancer segment accounts for the largest share in 2021. Breast cancer segment is the second-largest share during the forecast period 2022-2028. Based on the Application, the segment has been segregated into Clinical Diagnostics, Research Application. The clinical diagnostics segment is expected to dominate other segments in the market. 

Immuno Oncology Assays Market Key Developments

  • In July 2020, The HTG EdgeSeq Pan B-Cell Lymphoma Panel was launched by HTG Molecular Diagnostics, Inc. (US).

summary download arrow Download Free Sample

Immuno Oncology Assays Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.5%

Largest Market

North American

Fastest Growing Market

Asia-Pacific

Immuno Oncology Assays Market Dynamics

In order to diagnose and cure cancer, there is a great demand for research, and immuno-oncology assays play a significant role in this research due to the rise in incidence and prevalence of the disease is burgeon the market growth over the forecast years.

Immuno Oncology Assays Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 2,798.6 million

Market CAGR

12.5%

By Product Type

  • Instruments
  • Reagents and Kits
  • Software and Services

By Technology

  • Immunoassay
  • Polymerase chain reaction (PCR)
  • Next-generation sequencing (NGS)
  • Flow Cytometry
  • Others

By Indication

  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Melanoma Cancer
  • Bladder Cancer
  • Others

By Application

  • Clinical Diagnostics
  • Research
  • Application

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Features of the Report

  • The Immuno oncology assays market provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The market covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The market outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The market tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The market provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market.  
     

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global immuno oncology assays market size was valued at US$ 2,798.6 million in 2023 and is expected to grow at a CAGR of 12.5% from 2024 to 2030.

Based on technology, the global Immuno Oncology Assays Market is segmented into Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others. Among these, the Polymerase chain reaction (PCR) segment is expected to have the fastest-growing market during the forecast period 2024-2030.

The key market players are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Illumina, Inc. (US), NanoString Technologies, Inc. (US), Sartorius AG(Germany), HTG Molecular Diagnostics, Inc. (US), QIAGEN N.V. (Netherlands), Merck Millipore (US), PerkinElmer, Inc. (US), Abbott Laboratories, Inc. (US), Guardant Health, Inc. (US), bioMérieux SA

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Immuno Oncology Assays Market Introduction
2.1. Global Immuno Oncology Assays Market - Taxonomy
2.2. Global Immuno Oncology Assays Market -Definitions
2.2.1. By Product Type
2.2.2. By Technology
2.2.3. By Indication
2.2.4. By Application
2.2.5. By Region
3. Global Immuno Oncology Assays Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Immuno Oncology Assays Market Dynamic Factors - Impact Analysis
3.6. Global Immuno Oncology Assays Market - Competition Landscape
4. Global Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Immuno Oncology Assays Market, By Product Type, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.1. Instruments
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Reagents and Kits
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software and Services
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Immuno Oncology Assays Market, By Technology, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.1. Immunoassay
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Polymerase chain reaction (PCR)
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Next-generation sequencing (NGS)
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Flow Cytometry
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Immuno Oncology Assays Market, By Indication, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.1. Breast Cancer
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Colorectal Cancer
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Lung Cancer
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Melanoma Cancer
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Bladder Cancer
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Immuno Oncology Assays Market, By Application, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
8.1. Clinical Diagnostics
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Research Application
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Global Immuno Oncology Assays Market Forecast, By Region, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Region, 2024-2030
10. North America Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
10.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.2. Reagents and Kits
10.1.3. Software and Services
10.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Immunoassay
10.2.2. Polymerase chain reaction (PCR)
10.2.3. Next-generation sequencing (NGS)
10.2.4. Flow Cytometry
10.2.5. Others
10.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Breast Cancer
10.3.2. Colorectal Cancer
10.3.3. Lung Cancer
10.3.4. Melanoma Cancer
10.3.5. Bladder Cancer
10.3.6. Others
10.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Clinical Diagnostics
10.4.2. Research Application
10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030
10.7. North America Immuno Oncology Assays Market Dynamics - Trends
11. Europe Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
11.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.2. Reagents and Kits
11.1.3. Software and Services
11.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Immunoassay
11.2.2. Polymerase chain reaction (PCR)
11.2.3. Next-generation sequencing (NGS)
11.2.4. Flow Cytometry
11.2.5. Others
11.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Breast Cancer
11.3.2. Colorectal Cancer
11.3.3. Lung Cancer
11.3.4. Melanoma Cancer
11.3.5. Bladder Cancer
11.3.6. Others
11.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Clinical Diagnostics
11.4.2. Research Application
11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030
11.7. Europe Immuno Oncology Assays Market Dynamics - Trends
12. Asia-Pacific Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
12.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.2. Reagents and Kits
12.1.3. Software and Services
12.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Immunoassay
12.2.2. Polymerase chain reaction (PCR)
12.2.3. Next-generation sequencing (NGS)
12.2.4. Flow Cytometry
12.2.5. Others
12.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Breast Cancer
12.3.2. Colorectal Cancer
12.3.3. Lung Cancer
12.3.4. Melanoma Cancer
12.3.5. Bladder Cancer
12.3.6. Others
12.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Clinical Diagnostics
12.4.2. Research Application
12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030
12.7. Asia-Pacific Immuno Oncology Assays Market Dynamics - Trends
13. Latin America Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
13.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Instruments
13.1.2. Reagents and Kits
13.1.3. Software and Services
13.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Immunoassay
13.2.2. Polymerase chain reaction (PCR)
13.2.3. Next-generation sequencing (NGS)
13.2.4. Flow Cytometry
13.2.5. Others
13.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Breast Cancer
13.3.2. Colorectal Cancer
13.3.3. Lung Cancer
13.3.4. Melanoma Cancer
13.3.5. Bladder Cancer
13.3.6. Others
13.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Clinical Diagnostics
13.4.2. Research Application
13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030
13.7. Latin America Immuno Oncology Assays Market Dynamics - Trends
14. Middle East and Africa Immuno Oncology Assays Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn)
14.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Instruments
14.1.2. Reagents and Kits
14.1.3. Software and Services
14.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Immunoassay
14.2.2. Polymerase chain reaction (PCR)
14.2.3. Next-generation sequencing (NGS)
14.2.4. Flow Cytometry
14.2.5. Others
14.3. Indication Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Breast Cancer
14.3.2. Colorectal Cancer
14.3.3. Lung Cancer
14.3.4. Melanoma Cancer
14.3.5. Bladder Cancer
14.3.6. Others
14.4. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Clinical Diagnostics
14.4.2. Research Application
14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Immuno Oncology Assays Market - Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2024-2030
14.7. MEA Immuno Oncology Assays Market Dynamics - Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Agilent Technologies, Inc.
15.2.2. Thermo Fisher Scientific, Inc.
15.2.3. PerkinElmer, Inc.
15.2.4. Illumina, Inc.
15.2.5. PerkinElmer, Inc.
15.2.6. Crown Bioscience Inc.
15.2.7. InSphero, Inc.
15.2.8. Merck & Company, Inc.
15.2.9. F.Hoffmann-La Roche Ltd.
15.2.10. HTG Molecular Diagnostics, Inc.
15.2.11. Miltenyi Biotec
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Crown Bioscience Inc.
  • InSphero, Inc.
  • Merck & Company, Inc.
  • F.Hoffmann-La Roche Ltd.
  • HTG Molecular Diagnostics, Inc.
  • Miltenyi Biotec

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market